Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Elite Pharmaceuticals, Inc. To Host Conference Call To Provide Corporate Update And Discuss Third Quarter 2022 Financial Results On February 15, 2022

Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022

NORTHVALE, NJ / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC PINK:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that the third quarter financial results of the 2022 fiscal year will be released on Monday, February 14, 2022. Elite's management will host a live conference call Tuesday, February 15th at 11:30 AM EST to discuss the company's financial and operating results and provide a general business update. Stockholders should submit questions to the company prior to the call.

Date: February 15, 2022

Time: 11:30 AM EST

Dial- in numbers: 1-800-346-7359 (domestic)

1-973-528-0008 (international)

Conference number: 98840

Questions: [e-mail]

General questions by 5:00 PM EST on Saturday February 12, 2022

Financial questions by 7:00 PM EST on Monday, February 14, 2022
Audio Replay: https://elite.irpass.com/events_presentations

About Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.